203 related articles for article (PubMed ID: 22561473)
21. Hyperammonemia induced by interaction of valproate and quetiapine.
Halaby A; Haddad R; Naja WJ
Curr Drug Saf; 2013 Sep; 8(4):284-6. PubMed ID: 23962184
[TBL] [Abstract][Full Text] [Related]
22. Sexual disinhibition in schizophrenia possibly induced by risperidone and quetiapine.
Lam MH; Fong SY; Wing YK
Psychiatry Clin Neurosci; 2007 Jun; 61(3):333. PubMed ID: 17472606
[No Abstract] [Full Text] [Related]
23. Quetiapine-induced leucopenia and thrombocytopenia.
Shankar BR
Psychosomatics; 2007; 48(6):530-1. PubMed ID: 18071101
[TBL] [Abstract][Full Text] [Related]
24. A rare occurrence of isolated neutropenia with valproic acid: a case report.
Chakraborty S; Chakraborty J; Mandal S; Ghosal MK
J Indian Med Assoc; 2011 May; 109(5):345-6. PubMed ID: 22187773
[TBL] [Abstract][Full Text] [Related]
25. Reversible taste and smell dysfunction associated with sodium valproate and quetiapine in bipolar depression: a case report.
Alvarez P; Papaseit E; Pérez V; Bulbena A; Farré M
Actas Esp Psiquiatr; 2019 Jan; 47(1):33-6. PubMed ID: 30724329
[No Abstract] [Full Text] [Related]
26. Reversible parkinsonism and cognitive decline due to a possible interaction of valproic acid and quetiapine.
De Dios C; Fudio S; Lorenzo A
J Clin Pharm Ther; 2011 Jun; 36(3):430-2. PubMed ID: 21545624
[TBL] [Abstract][Full Text] [Related]
27. Valproic Acid-related anticonvulsant hypersensitivity syndrome and subsequent olanzapine-related neutropenia and thrombocytopenia: a case report.
Lin YH; Chien YL
J Clin Psychopharmacol; 2012 Feb; 32(1):132-3. PubMed ID: 22217947
[No Abstract] [Full Text] [Related]
28. Decision model for the acute treatment of mania.
Steffens DC; Krishnan KR
Depress Anxiety; 1996-1997; 4(6):289-93. PubMed ID: 9166657
[TBL] [Abstract][Full Text] [Related]
29. Combination treatment with quetiapine in bipolar disorder patients.
Basu D; Chakraborty K
Am J Psychiatry; 2009 Oct; 166(10):1185; author reply 1186-7. PubMed ID: 19797447
[No Abstract] [Full Text] [Related]
30. Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study.
Merideth C; Cutler AJ; She F; Eriksson H
Int Clin Psychopharmacol; 2012 Jan; 27(1):40-54. PubMed ID: 22045039
[TBL] [Abstract][Full Text] [Related]
31. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
Ketter TA
J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
[TBL] [Abstract][Full Text] [Related]
32. Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania.
McElroy SL; Martens BE; Creech RS; Welge JA; Jefferson L; Guerdjikova AI; Keck PE
J Clin Psychiatry; 2010 May; 71(5):557-65. PubMed ID: 20361901
[TBL] [Abstract][Full Text] [Related]
33. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
Lee JH; Dunner DL
Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
[TBL] [Abstract][Full Text] [Related]
34. Cingulate gyrus volumetry in drug free bipolar patients and patients treated with valproate or valproate and quetiapine.
Atmaca M; Ozdemir H; Cetinkaya S; Parmaksiz S; Belli H; Poyraz AK; Tezcan E; Ogur E
J Psychiatr Res; 2007 Nov; 41(10):821-7. PubMed ID: 16950400
[TBL] [Abstract][Full Text] [Related]
35. Acute nonpsychotic mania: first episode.
Allen MH
CNS Spectr; 2009 Nov; 14(11 Suppl 11):3-6; discussion 12-4. PubMed ID: 20173693
[No Abstract] [Full Text] [Related]
36. Quetiapine for mania with Wilson's disease.
Kulaksizoglu IB; Polat A
Psychosomatics; 2003; 44(5):438-9. PubMed ID: 12954924
[No Abstract] [Full Text] [Related]
37. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study.
Berwaerts J; Lane R; Nuamah IF; Lim P; Remmerie B; Hough DW
J Affect Disord; 2011 Mar; 129(1-3):252-60. PubMed ID: 20947174
[TBL] [Abstract][Full Text] [Related]
38. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder.
Post RM; Altshuler LL; Frye MA; Suppes T; Keck PE; McElroy SL; Leverich GS; Luckenbaugh DA; Rowe M; Pizzarello S; Kupka RW; Grunze H; Nolen WA
J Clin Psychiatry; 2010 Sep; 71(9):1176-86; quiz 1252-3. PubMed ID: 20923622
[TBL] [Abstract][Full Text] [Related]
39. Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine.
Atmaca M; Yildirim H; Ozdemir H; Ogur E; Tezcan E
Psychol Med; 2007 Jan; 37(1):121-9. PubMed ID: 17094813
[TBL] [Abstract][Full Text] [Related]
40. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
